Diagnosticos da AmericaBSP:DASA3 -6.09%53 Days Inventory is 11.28 as of Mar. 2026, which is 26% below its 10-year median of 15.21. GuruFocus rates BSP:DASA3 with a GF Score™ of 53/100 and a GF Value™ of R$1.70 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Diagnosticos da America ranks better than 92.09% on this metric.
The historical rank and industry rank for Diagnosticos da America's Days Inventory or its related term are showing as below:
BSP:DASA3'
s Days Inventory Range Over the Past 10 Years
Min: 12.27 Med: 15.21 Max: 18.12
Current: 14.93
During the past 13 years, Diagnosticos da America's highest Days Inventory was 18.12. The lowest was 12.27. And the median was 15.21.
BSP:DASA3's Days Inventory is ranked better than 92.09% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 70.8
vs BSP:DASA3: 14.93
Diagnosticos da America's Days Inventory
declined
from Mar. 2025 (16.13) to Mar. 2026 (11.28).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Diagnosticos da America's Inventory Turnover for the
three
months ended in Mar. 2026 was 8.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Diagnosticos da America's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.08.
Diagnosticos da America (BSP:DASA3) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Diagnosticos da America's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Diagnosticos da America's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Diagnosticos da America Days Inventory Related Terms
Diagnosticos da America Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:DASA3 vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Diagnosticos da America's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnosticos da America Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's Days Inventory distribution charts can be found below:
* The bar in red indicates where Diagnosticos da America's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnosticos da America (BSP:DASA3) has a Days Inventory of 11.28 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Diagnosticos da America and its competitors. This is 26% below median its historical median of 15.21. Over the past decade, Diagnosticos da America's Days Inventory has ranged from 12.27 to 18.12. According to the industry distribution chart, Diagnosticos da America ranks #14 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 7.9%.
Is Diagnosticos da America's Days Inventory too high?
Diagnosticos da America's current Days Inventory of 11.28 is 26% below median its 10-year median of 15.21. Over the past 10 years, this metric has ranged from a low of 12.27 to a high of 18.12. The Medical Diagnostics & Research industry median Days Inventory is 70.80. Diagnosticos da America's value of 11.28 is 84.1% below this industry median. Based on the distribution chart, Diagnosticos da America ranks #14 out of 177 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Diagnosticos da America has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diagnosticos da America ranks #14 out of 177 companies for Days Inventory. This places Diagnosticos da America in the top 8% of its industry — outperforming the majority of peers. The industry median Days Inventory is 70.80. Diagnosticos da America's value of 11.28 is 84.1% below this benchmark. Historically, Diagnosticos da America's own Days Inventory has ranged from 12.27 to 18.12 over the past decade. While the company's 10-year median is 15.21 vs. the industry median of 70.80, Diagnosticos da America has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 70.80, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnosticos da America's current Days Inventory of 11.28 is 84.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Diagnosticos da America and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 70.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnosticos da America's current Days Inventory is 11.28, which is 26% below median its own 10-year median of 15.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.70, compared to a current price of R$2.62 — trading 54.1% above its estimated fair value. The current Days Inventory is 11.28, which is 26% below median its 10-year median of 15.21 and 84.1% below the Medical Diagnostics & Research industry median of 70.80. Diagnosticos da America's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Days Inventory is 11.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued.
The current stock price of R$2.62 is trading 54.1% above its estimated GF Value™ of R$1.70.
GuruFocus considers Diagnosticos da America to be Significantly Overvalued.
Key valuation signals for BSP:DASA3:
Days Inventory: 11.28 (26% below median its 10-year median of 15.21)
GF Value™: R$1.70 vs. price of R$2.62 (54.1% above fair value)
Industry Position: 84.1% below the Medical Diagnostics & Research median (#14 of 177)
No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
53GF Score
Get the complete analysis for BSP:DASA3
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DASA3 has been successfully added to your 
